Form 8-K · Current report
Procter & Gamble 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000080424
- Accession no.
- 0000080424-26-000097
Summary
Procter & Gamble reported fiscal 2026 fourth-quarter and full-year results, with full-year organic sales growth of 1% and core EPS of $6.89, and issued fiscal 2027 guidance for organic and net sales growth of 1% to 3%. For the fourth quarter, organic sales were flat and core EPS declined 3%.
Key points
- P&G's FY2026 organic sales grew 1% year over year, with volume flat and pricing up 1%; core EPS was $6.89, up 1%.
- In Q4 FY2026, organic sales were flat year over year, and core EPS declined 3%, or 5% on a currency-neutral basis.
- P&G guided FY2027 organic sales growth and net sales growth at 1% to 3%, core EPS growth at 0% to 3%, and all-in EPS growth at 1% to 5%.
- FY2026 adjusted free cash flow productivity was 100%, and Q4 FY2026 adjusted free cash flow productivity was 133%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 - Regulation FD Disclosure On July 29, 2026, The Procter & Gamble Company (the "Company") issued a press release announcing its fourth quarter and fiscal year 2026 results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure." Item 9.01 - Financial Statements and Exhibits (d): The following exhibits are being filed herewith: Exhibit No. Description 99.1 Informational Slides Provided by The Procter & Gamble Company dated July 29, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.